Gene therapy for CDs: Certain genes such as visual system homeobox 1 (VSX1), dedicator of cytokinesis 9 (DOCK9), or transforming growth factor-beta (TGFB1) may have an essential, sufficient role in the disease. The gene discussed is DOCK9; the disease is cerebral creatine deficiency syndrome.